Importantly, high ARHGAP5‐AS1 levels in HCC specimens were also correlated with shortened time of progression free survival (PFS) (Log‐rank p = 0.001) or overall survival (OS) (Log‐rank p = 0.005) (Figure 2B). This evidence concerns the gene ARHGAP5 and hepatocellular carcinoma.